局灶性脑缺血与再灌注通过α2δ-1结合型NMDA受体诱导脑损伤
该研究在小鼠大脑中动脉闭塞90分钟再灌注24小时模型中,发现缺血增加α2δ-1糖基化并增强α2δ-1与NMDA受体的物理结合;抑制α2δ-1或阻断其与NMDA受体结合可消除氧糖剥夺诱导的NMDA受体过度活跃,并减少梗死体积、神经功能缺损评分及钙蛋白酶/胱天蛋白酶-3激活。
要点
- 小鼠大脑中动脉闭塞90分钟再灌注24小时可增加皮层、海马和纹状体α2δ-1蛋白糖基化。
- 抑制α2δ-1或阻断α2δ-1-NMDA受体结合不影响基础NMDA受体电流,但消除氧糖剥夺诱导的过度活跃。
- 加巴喷丁、α2δ-1 C端干扰肽或Cacna2d1基因敲除可减少梗死体积、神经功能缺损评分及钙蛋白酶/胱天蛋白酶-3激活。
核心结论
- α2δ-1是脑缺血诱导神经元NMDA受体过度活跃所必需,α2δ-1结合型NMDA受体介导脑缺血所致脑损伤。
- 靶向α2δ-1结合型NMDA受体而不损害生理性α2δ-1游离NMDA受体,可能是治疗缺血性卒中的有前景策略。
研究设计与样本
- 小鼠经历90分钟大脑中动脉闭塞后24小时再灌注,测量神经功能缺损、脑梗死体积及脑组织钙蛋白酶/胱天蛋白酶-3活性。
- 在海马CA1神经元体外缺血模型中测量NMDA受体活性。
主要发现
- 大脑中动脉闭塞增加大脑皮层、海马和纹状体α2δ-1蛋白糖基化。
- 免疫共沉淀显示缺血快速增强小鼠脑组织中α2δ-1与NMDA受体的物理相互作用。
- 加巴喷丁抑制α2δ-1、α2δ-1 C端干扰肽解偶联α2δ-1-NMDA受体相互作用或Cacna2d1基因敲除对基础NMDA受体电流无影响,但显著消除氧糖剥夺诱导的海马CA1神经元NMDA受体过度活跃。
- 全身给予加巴喷丁或α2δ-1 C端干扰肽或Cacna2d1基因敲除减少大脑中动脉闭塞诱导的梗死体积、神经功能缺损评分及脑组织钙蛋白酶/胱天蛋白酶-3激活。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Glutamate NMDARs (N-methyl-D-aspartate receptors) play a major role in the initiation of ischemic brain damage. However, NMDAR antagonists have no protective effects in stroke patients, possibly because they impair physiological functions of NMDARs. α2δ-1 (encoded by Cacna2d1) is strongly expressed in many brain regions. We determined the contribution of α2δ-1 to NMDAR hyperactivity and brain injury induced by ischemia and reperfusion. Methods- Mice were subjected to 90 minutes of middle cerebral artery occlusion followed by 24 hours of reperfusion. Neurological deficits, brain infarct volumes, and calpain/caspase-3 activity in brain tissues were measured. NMDAR activity of hippocampal CA1 neurons was measured in an in vitro ischemic model. Results- Middle cerebral artery occlusion increased α2δ-1 protein glycosylation in the cerebral cortex, hippocampus, and striatum. Coimmunoprecipitation showed that ischemia rapidly enhanced the α2δ-1-NMDAR physical interaction in the mouse brain tissue. Inhibiting α2δ-1 with gabapentin, uncoupling the α2δ-1-NMDAR interaction with an α2δ-1 C terminus-interfering peptide, or genetically ablating Cacna2d1 had no effect on basal NMDAR currents but strikingly abolished oxygen-glucose deprivation-induced NMDAR hyperactivity in hippocampal CA1 neurons. Systemic treatment with gabapentin or α2δ-1 C-terminus-interfering peptide or Cacna2d1 genetic knock-out reduced middle cerebral artery occlusion-induced infarct volumes, neurological deficit scores, and calpain/caspase-3 activation in brain tissues. Conclusions- α2δ-1 is essential for brain ischemia-induced neuronal NMDAR hyperactivity, and α2δ-1-bound NMDARs mediate brain damage caused by cerebral ischemia. Targeting α2δ-1-bound NMDARs, without impairing physiological α2δ-1-free NMDARs, may be a promising strategy for treating ischemic stroke.
引用
- Luo Y, Ma H, Zhou JJ, et al. Focal Cerebral Ischemia and Reperfusion Induce Brain Injury Through α2δ-1-Bound NMDA Receptors. Stroke. 2018. PMID: 30355118. doi:10.1161/STROKEAHA.118.022330
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。